AstraZeneca is a global, science-led biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative medicines and improving access to them. Its therapy areas cover oncology, rare disease and biopharmaceuticals, including cardiovascular, renal and metabolism, and respiratory and immunology. It has 11 R&D centres in five countries and 28 manufacturing sites across 16 countries. AstraZeneca sells its medicines to more than 130 countries and its main disease area medicines (excluding the vaccine) impact more than 100 million patient lives each year. In 2021, total revenue was $37.4 billion and $9.7 billion was invested in science and R&D.
What’s inspired, informed, delighted and impressed the top leaders in business and civil society? In this second annual book recommendation episode, learn the top books recommended by CEO...
With a career that spans nearly 5 decades in science and technology -- one that includes time at AstraZeneca during its history making effort to deliver billions of vaccines to countries ...
The Centre for Advanced Manufacturing and Supply Chains is enabling more resilient, sustainable and inclusive manufacturing ecosystems and supply chains.TheCentre for Advanced Manufacturi...
The Centre for Health and Healthcare identifies and scales up solutions for more resilient, efficient, and equitable healthcare systems..In the next decade, healthcare delivery systems wi...
The Centre for Nature and Climate accelerates net-zero climate action, regenerates food, water and ocean systems, and promotes circular economies.Global ecological systems are straining u...
